# Nanophase Technologies Corporation – FDA Inspection, Jan 9, 2026

Source: https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/15d88410-e532-46d7-80a1-b982caf658e5
Source feed: FDA_Inspections

> FDA inspection 1298600 of Nanophase Technologies Corporation, January 09, 2026. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1298600
- Company Name: Nanophase Technologies Corporation
- Inspection Date: 2026-01-09
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Chicago District Office
- Citation Count: 0

## Related Documents

- [FDA Inspection 1205286 - 2023-04-13](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/22d2e70e-237e-4e93-9811-df1e87ad4563)
- FDA Inspection 1096141 - 2019-06-07
- FDA Inspection 1077501 - 2018-11-29
- FDA Inspection 896947 - 2014-09-15
- FDA Inspection 753672 - 2011-11-17

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/kelly-m-bromley/964704be-b203-4c56-b1d7-6144e9e0236e)
- [Issuing Officer](https://www.keypedia.com/people/tyler-m-peterson/207310ee-260c-4618-a515-9895a56e2ede)

Company: https://www.keypedia.com/companies/nanophase-technologies-corporation/2b2b4bbe-7d35-4ece-8a79-dbffc6f82a51

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669
